{"id":"W2544907814","doi":"10.3324/haematol.2016.151126","title":"Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health","keywords":"Myelofibrosis; Open label; Medicine; Ruxolitinib; Internal medicine; Oncology; Clinical trial; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001988454,0.0002351895,0.001571082,0.0004286576,0.00005668848,0.000007287428,0.0001431366,0.0001230167,0.0001343234],"category_scores_gemma":[0.0002090252,0.0001195426,0.0001137013,0.001185676,0.000149714,0.0001223232,0.0001658651,0.00007936088,0.000003911102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000125633,"about_ca_system_score_gemma":0.000174945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007566993,"about_ca_topic_score_gemma":0.00007074769,"domain_scores_codex":[0.998142,0.000138096,0.0006637048,0.0004345122,0.0003865203,0.0002351896],"domain_scores_gemma":[0.9984889,0.0002958252,0.0004368243,0.0003549166,0.0003211321,0.0001024011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1604449,0.04479516,0.7740943,0.0001086052,0.003103384,0.00006500406,0.0005664085,8.304739e-7,0.001808173,0.000777623,0.0004390224,0.0137966],"study_design_scores_gemma":[0.4078527,0.04921277,0.5030409,0.0007219176,0.002450973,0.000005587334,0.00004167961,0.00001666012,0.03618969,0.000101096,0.00009560669,0.0002703959],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960045,0.0000521153,0.0000315136,0.0003291071,0.00002813935,0.001996141,0.0001189291,0.0000156949,0.001423829],"genre_scores_gemma":[0.9977571,0.00004063416,0.001593236,0.000101543,0.000009880278,0.0003544536,0.00006810826,0.00001341564,0.00006167738],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2710534,"threshold_uncertainty_score":0.4874806,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02871582059334091,"score_gpt":0.3091379193859089,"score_spread":0.280422098792568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}